Back to Search
MICHELLE LOOK, MD
MD
Sports Medicine (Family Medicine) Physician
NPI: 1851402143IndividualAccepts Medicare
Specialties, Licenses & Credentials
Sports Medicine (Family Medicine) PhysicianPrimary
Family Medicine — Sports Medicine
Code: 207QS0010X
A62798(CA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
JEFFERSON MEDICAL COLLEGE OF THOMAS JEFFERSON UNIVERSITY
Class of 1995
Research & Publications (20)
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.
PMID 11792750·J Natl Cancer Inst·2002
8-other
Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer.
PMID 19329653·Mol Cell Proteomics·2009
8-other
Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer.
PMID 18629630·Breast Cancer Res Treat·2009
8-other
Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.
PMID 19075277·J Clin Oncol·2009
8-other
TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer.
PMID 18299979·Breast Cancer Res Treat·2009
8-other
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer.
PMID 18755890·Proc Natl Acad Sci U S A·2008
8-other
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients.
PMID 17965955·Breast Cancer Res Treat·2008
8-other
Double-blind, placebo-controlled trial of carisoprodol 250-mg tablets in the treatment of acute lower-back spasm.
PMID 18194591·Curr Med Res Opin·2008
4-observational
Demonstration of multi-analyte patterning using piezoelectric inkjet printing of multiple layers.
PMID 18298971·Anal Chim Acta·2008
8-other
Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer.
PMID 18310279·Endocr Relat Cancer·2008
8-other
The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles.
PMID 18006053·Biomaterials·2008
7-preclinical
Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response.
PMID 18765548·Clin Cancer Res·2008
8-other
Polymorphic variations in exon 10 of the luteinizing hormone receptor: functional consequences and associations with breast cancer.
PMID 17709176·Mol Cell Endocrinol·2007
8-other
Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma.
PMID 17163465·Head Neck·2007
8-other
HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study.
PMID 17308270·J Clin Oncol·2007
8-other
Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods.
PMID 17419953·J Clin Epidemiol·2007
1-meta
A new proposal for multivariable modelling of time-varying effects in survival data based on fractional polynomial time-transformation.
PMID 17623349·Biom J·2007
8-other
GnRH and LHR gene variants predict adverse outcome in premenopausal breast cancer patients.
PMID 17692113·Breast Cancer Res·2007
4-observational
Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer.
PMID 17114213·Clin Cancer Res·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6699 ALVARADO RD, SUITE 2100
SAN DIEGO, CA 92120 - Phone
- (619) 229-3909
Quick Facts
- NPI
- 1851402143
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile